Emergence of Ethnomedical COVID-19 Treatment: A Literature Review

References

• Ghebreyesus TA WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19. Presented at the: 2020: World Health Organization; 2020.
   Google Scholar
• Hsiang S, Allen D, Annan-Phan S, et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584(7820):262–267. doi:10.1038/s41586-020-2404-832512578
   PubMed Web of Science ®Google Scholar
• Chinazzi M, Davis JT, Ajelli M, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400. doi:10.1126/science.aba975732144116
   PubMed Web of Science ®Google Scholar
• Bookwalter CM. Drug Shortages Amid the COVID-19 Pandemic. US Pharm. 2021;46(2):25–28.
   Web of Science ®Google Scholar
• Badreldin HA, Atallah B. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Soc Adm Pharm. 2021;17(1):1946–1949. doi:10.1016/j.sapharm.2020.05.017
   Web of Science ®Google Scholar
• Saag MS. Misguided Use of Hydroxychloroquine for COVID-19. JAMA. 2020;324(21):2161. doi:10.1001/jama.2020.2238933165507
   PubMed Web of Science ®Google Scholar
• Hu K, Guan W, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2021;85:153242. doi:10.1016/j.phymed.2020.15324233867046
   PubMed Web of Science ®Google Scholar
• Zeng M, Li L, Wu Z. Traditional Chinese medicine Lianhua Qingwen treating Corona virus disease 2019(COVID-19): meta-analysis of randomized controlled trials. Serra Red. PLoS One. 2020;15(9):e0238828. doi:10.1371/journal.pone.023882832915877
   PubMed Web of Science ®Google Scholar
• Yang Y. Use of herbal drugs to treat COVID-19 should be with caution. Lancet. 2020;395(10238):1689–1690. doi:10.1016/S0140-6736(20)31143-032422123
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO supports scientifically proven traditional medicine; 2020. Accessed April 23, 2021. https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine.
   Google Scholar
• Ang L, Song E, Lee HW, Lee MS. Herbal medicine for the treatment of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2020;9(5):1583. doi:10.3390/jcm9051583
   PubMed Web of Science ®Google Scholar
• Pu J, Mei H, Lei L, et al. Knowledge of medical professionals, their practices, and their attitudes toward traditional Chinese medicine for the prevention and treatment of coronavirus disease 2019: a survey in Sichuan, China. PLoS One. 2021;16(3):e0234855. doi:10.1371/journal.pone.023485533725021
   PubMed Web of Science ®Google Scholar
• Xu S, Levine M. Medical residents’ and students’ attitudes towards herbal medicines: a pilot study. Can J Clin Pharmacol. 2008;15(1):e1–4.18184982
   PubMedGoogle Scholar
• Gyasi RM, Abass K, Adu-Gyamfi S, Accam BT. Nurses’ knowledge, clinical practice and attitude towards unconventional medicine: implications for intercultural healthcare. Complement Ther Clin Pract. 2017;29:1–8. doi:10.1016/j.ctcp.2017.07.00129122246
   PubMed Web of Science ®Google Scholar
• Hilal M, Hilal S. Knowledge, attitude, and utilization of herbal medicines by physicians in the Kingdom of Bahrain: a cross-sectional study. J Assoc Arab Univ Basic Appl Sci. 2017;24(1):325–333. doi:10.1016/j.jaubas.2016.11.001
   Google Scholar
• Alzahrani SH, Bashawri J, Salawati EM, Bakarman MA. Knowledge and attitudes towards complementary and alternative medicine among senior medical students in King Abdulaziz University, Saudi Arabia. Evid Based Complement Altern Med. 2016;2016:9370721. doi:10.1155/2016/9370721
   Web of Science ®Google Scholar
• Shelley BM, Sussman AL, Williams RL, Segal AR, Crabtree BF. “They don’t ask me so I don’t tell them”: patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med. 2009;7(2):139–147. doi:10.1370/afm.94719273869
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Kumar N, Tillu G, Deshpande S, Patwardhan B. AYUSH, modern medicine and the Covid-19 pandemic. Indian J Med Ethics. 2020;05(03):191–195. doi:10.20529/IJME.2020.058
   Google Scholar
• Grimes DR. Medical disinformation and the unviable nature of COVID-19 conspiracy theories. Serra Red. PLoS One. 2021;16(3):e0245900. doi:10.1371/journal.pone.024590033711025
   PubMed Web of Science ®Google Scholar
• Tillu G, Chaturvedi S, Chopra A, Patwardhan B. Public health approach of ayurveda and yoga for COVID-19 prophylaxis. J Altern Complement Med. 2020;26(5):360–364. doi:10.1089/acm.2020.012932310670
   PubMed Web of Science ®Google Scholar
• Donma MM, Donma O. The effects of Allium sativum on immunity within the scope of COVID-19 infection. Med Hypotheses. 2020;144:109934. doi:10.1016/j.mehy.2020.10993432512493
   PubMed Web of Science ®Google Scholar
• Batiha GE-S, Beshbishy AM, Wasef LG, et al. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): a review. Nutrients. 2020;12(3):872. doi:10.3390/nu12030872
   Web of Science ®Google Scholar
• Keyaerts E, Vijgen L, Pannecouque C, et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007;75(3):179–187. doi:10.1016/j.antiviral.2007.03.00317428553
   PubMed Web of Science ®Google Scholar
• Dandara C, Dzobo K, Chirikure S. COVID-19 pandemic and Africa: from the situation in Zimbabwe to a case for precision herbal medicine. Omi a J Integr Biol. 2021;25(4):209–212. doi:10.1089/omi.2020.0099
   PubMed Web of Science ®Google Scholar
• Mwai P. Coronavirus: what do we know about the Artemisia plant? BBC. Published 2020. Accessed June 22, 2021. https://www.bbc.com/news/world-africa-53484298.
   Google Scholar
• Cao R, Hu H, Li Y, et al. Anti-SARS-CoV-2 potential of artemisinins in vitro. ACS Infect Dis. 2020;6(9):2524–2531. doi:10.1021/acsinfecdis.0c0052232786284
   PubMed Web of Science ®Google Scholar
• Gruessner BM, Cornet-Vernet L, Desrosiers MR, Lutgen P, Towler MJ, Weathers PJ. It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis. Phytochem Rev. 2019;18(6):1509–1527. doi:10.1007/s11101-019-09645-933911989
   PubMed Web of Science ®Google Scholar
• Rolta R, Salaria D, Kumar V, Sourirajan A, Dev K. Phytocompounds of Rheum emodi, Thymus serpyllum and Artemisia annua inhibit COVID-19 binding to ACE2 receptor: in silico approach. Res Sq Preprint. 2020. doi:10.21203/rs.3.rs-30938/v1
   Google Scholar
• Chikhale RV, Sinha SK, Patil RB, et al. In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19. J Biomol Struct Dyn. 2021;39(14):5033–5047. doi:10.1080/07391102.2020.178428932579064
   PubMed Web of Science ®Google Scholar
• Bopana N, Saxena S. Asparagus racemosus—Ethnopharmacological evaluation and conservation needs. J Ethnopharmacol. 2007;110(1):1–15. doi:10.1016/j.jep.2007.01.00117240097
   PubMed Web of Science ®Google Scholar
• Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): a review. Asian Pacific J Trop Dis. 2013;3(3):242–251. doi:10.1016/S2222-1808(13)60049-3
   Google Scholar
• Xu J, Zhang Y. Traditional Chinese Medicine treatment of COVID-19. Complement Ther Clin Pract. 2020;39:101165. doi:10.1016/j.ctcp.2020.10116532379692
   PubMed Web of Science ®Google Scholar
• Li C, Wang L, Ren L. Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus Res. 2020;286:198073. doi:10.1016/j.virusres.2020.19807332592817
   PubMed Web of Science ®Google Scholar
• Fu L, Lin J, Yao M, Niu F, Ma F, Wang L. Clinical observation on treatment of cough during pregnancy with modified Baihe Gujin Decoction. Tradit Med Mod Med. 2020;03(02):117–122. doi:10.1142/S2575900020500081
   Google Scholar
• Gupta H, Gupta M, Bhargava S. Potential use of turmeric in COVID‐19. Clin Exp Dermatol. 2020;45(7):902–903. doi:10.1111/ced.1435732608046
   PubMed Web of Science ®Google Scholar
• Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): new treatment option against COVID‐19. Food Sci Nutr. 2020;8(10):5215–5227. doi:10.1002/fsn3.185833133525
   PubMed Web of Science ®Google Scholar
• Emirik M. Potential therapeutic effect of turmeric contents against SARS-CoV-2 compared with experimental COVID-19 therapies: in silico study. J Biomol Struct Dyn. 2020;1–14. doi:10.1080/07391102.2020.1835719
   Web of Science ®Google Scholar
• Krup V. Pharmacological activities of turmeric (Curcuma longa Linn): a Review. J Homeopath Ayurvedic Med. 2013;2(4). doi:10.4172/2167-1206.1000133
   Google Scholar
• Kumar SB, Krishna S, Pradeep S, et al. Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (Mpro): an integrated computational approach. Comput Biol Med. 2021;134:104524. doi:10.1016/j.compbiomed.2021.10452434090015
   PubMed Web of Science ®Google Scholar
• Kamala A, Middha SK, Karigar CS. Plants in traditional medicine with special reference to Cyperus rotundus L.: a review. 3 Biotech. 2018;8(7):309. doi:10.1007/s13205-018-1328-6
   PubMedGoogle Scholar
• Ren J, Zhang A-H, Wang X-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020;155:104743. doi:10.1016/j.phrs.2020.10474332145402
   PubMed Web of Science ®Google Scholar
• Lee DYW, Li QY, Liu J, Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19: clinical experience and scientific basis. Phytomedicine. 2021;80:153337. doi:10.1016/j.phymed.2020.15333733221457
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhao S, Yang S, et al. An “essential herbal medicine”—licorice: a review of phytochemicals and its effects in combination preparations. J Ethnopharmacol. 2020;249:112439. doi:10.1016/j.jep.2019.11243931811935
   PubMed Web of Science ®Google Scholar
• Feng Yeh C, Chih Wang K, Chai Chiang L, Shieh DE, Hong Yen M, San Chang J. Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J Ethnopharmacol. 2013;148(2):466–473. doi:10.1016/j.jep.2013.04.04023643542
   PubMed Web of Science ®Google Scholar
• Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine. 2005;12(9):684–701. doi:10.1016/j.phymed.2004.07.00916194058
   PubMed Web of Science ®Google Scholar
• Bailly C, Vergoten G. Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol Ther. 2020;214:107618. doi:10.1016/j.pharmthera.2020.10761832592716
   PubMed Web of Science ®Google Scholar
• Keck T, Strobl A, Weinhaeusel A, Funk P, Michaelis M. Pelargonium extract EPs 7630 in the treatment of human corona virus-associated acute respiratory tract infections – a secondary subgroup-analysis of an open-label, uncontrolled clinical trial. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.666546
   Web of Science ®Google Scholar
• Michaelis M, Doerr HW, Cinatl J. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011;18(5):384–386. doi:10.1016/j.phymed.2010.09.00821036571
   PubMed Web of Science ®Google Scholar
• Conrad A, Kolodziej H, Schulz V. Pelargonium sidoides-Extrakt (EPs® 7630): zulassung bestätigt Wirksamkeit und Verträglichkeit. Wiener Medizinische Wochenschrift. 2007;157(13–14):331–336. doi:10.1007/s10354-007-0434-617704982
   PubMedGoogle Scholar
• Wu L, Chen Y, Ma Y, et al. Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines. Pharmacol Res. 2020;160:105101. doi:10.1016/j.phrs.2020.10510132739428
   PubMed Web of Science ®Google Scholar
• Hu C, Liang M, Gong F, He B, Zhao D, Zhang G. Efficacy of Lianhua Qingwen compared with conventional drugs in the treatment of common pneumonia and COVID-19 pneumonia: a meta-analysis. Evid Based Complement Altern Med. 2020;2020:1–15. doi:10.1155/2020/5157089
   Web of Science ®Google Scholar
• Li L-C, Zhang Z-H, Zhou W-C, et al. Lianhua Qingwen prescription for coronavirus disease 2019 (COVID-19) treatment: advances and prospects. Biomed Pharmacother. 2020;130:110641. doi:10.1016/j.biopha.2020.11064134321172
   PubMed Web of Science ®Google Scholar
• Wang C, Cao B, Liu -Q-Q, et al. Oseltamivir compared with the Chinese traditional therapy Maxingshigan–Yinqiaosan in the treatment of H1N1 influenza. Ann Intern Med. 2011;155(4):217. doi:10.7326/0003-4819-155-4-201108160-0000521844547
   PubMed Web of Science ®Google Scholar
• Shao G, Huang S, Cui Y, Yang D. Maxingshigan decoction for treating COVID-19. Medicine. 2020;99(48):e23224. doi:10.1097/MD.000000000002322433235080
   PubMed Web of Science ®Google Scholar
• Kageyama Y, Aida K, Kawauchi K, et al. Qingfei Paidu decoction, a Chinese herbal medicine against COVID‑19, elevates the blood levels of pro‑inflammatory cytokines: an open‑label, single‑arm pilot study. World Acad Sci J. 2021;3(3):25. doi:10.3892/wasj.2021.96
   Google Scholar
• Ren W, Ma Y, Wang R, et al. Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application. Front Pharmacol. 2021;11. doi:10.3389/fphar.2020.589714
   Web of Science ®Google Scholar
• Chen J, Wang Y, Gao Y, et al. Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming. Biomed Pharmacother. 2020;129:110281. doi:10.1016/j.biopha.2020.11028132554251
   PubMed Web of Science ®Google Scholar
• Poon PMK, Wong CK, Fung KP, et al. Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study. Am J Chin Med. 2006;34(01):13–21. doi:10.1142/S0192415X0600359X16437735
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhang M, Yi Z, Wen C, Qian M, Shi T. Replacements of rare herbs and simplifications of traditional Chinese medicine formulae based on attribute similarities and pathway enrichment analysis. Evid Based Complement Altern Med. 2013;2013:1–9. doi:10.1155/2013/136732
   Web of Science ®Google Scholar
• Yin L, Zeng Y, Huang X, Hou H. Effects of Forsythia suspensa extract on cell proliferation and activation of the mouse T lymphocytes in vitro. Chinese J Cell Mol Immunol. 2008;24(1):10–12.
   Google Scholar
• Pi Q, Tan W, Tan Z. A narrative review of the scientific natures of the prevention and treatment of COVID-19 with traditional Chinese medicine. Longhua Chin Med. 2021;1:4.
   Google Scholar
• Zhao Y, Pang X. Efficacy of Shegan Mahuang Decoction for asthma. Medicine. 2019;98(44):e17845. doi:10.1097/MD.000000000001784531689875
   PubMed Web of Science ®Google Scholar
• Lin -C-C, Wang -Y-Y, Chen S-M, et al. Shegan-Mahuang Decoction ameliorates asthmatic airway hyperresponsiveness by downregulating Th2/Th17 cells but upregulating CD4+FoxP3+ Tregs. J Ethnopharmacol. 2020;253:112656. doi:10.1016/j.jep.2020.11265632035217
   PubMed Web of Science ®Google Scholar
• Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16(10):1708–1717. doi:10.7150/ijbs.4553832226288
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen Q, Zhou W, et al. Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection: a systematic review of randomized controlled trials. Evid Based Complement Altern Med. 2013;2013:1–7. doi:10.1155/2013/987326
   Web of Science ®Google Scholar
• Ni L, Wen Z, Hu X, et al. Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial. Front Med. 2021. doi:10.1007/s11684-021-0853-6
   Web of Science ®Google Scholar
• Su H, Yao S, Zhao W, et al. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020;41(9):1167–1177. doi:10.1038/s41401-020-0483-632737471
   PubMed Web of Science ®Google Scholar
• Ngbolua K-N, Mbadiko CM, Matondo A, et al. Review on ethno-botany, virucidal activity, phytochemistry and toxicology of Solanum genus: potential bio-resources for the therapeutic management of Covid-19. Eur J Nutr Food Saf. 2020:35–48. doi:10.9734/ejnfs/2020/v12i730246
   Google Scholar
• Shree P, Mishra P, Selvaraj C, et al. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study. J Biomol Struct Dyn. 2020:1–14. doi:10.1080/07391102.2020.1810778
   Web of Science ®Google Scholar
• Ghosh S, Saha S. Tinospora cordifolia: one plant, many roles. Anc Sci Life. 2012;31(4):151. doi:10.4103/0257-7941.10734423661861
   PubMedGoogle Scholar
• Sabade M. Patho-physiology of COVID-19 and possible management principle from Ayurveda’s perspective. Ann Ayurvedic Med. 2020;9(3):171–175. doi:10.5455/AAM.109096
   Google Scholar
• Rathnayake H, De Zoysa MHN, Hewawasam RP, Weerasinghe MD. Comparison of In vitro antibacterial activity of Epaltes divaricata and Vetiveria zizanioides against methicillin-resistant Staphylococcus aureus. Scientifica. 2020;2020:1–8. doi:10.1155/2020/8239053
   Web of Science ®Google Scholar
• Kumar P, Chakraborthy GS, Mazumder A, Kumar K, Sodhi G, Rana SK. Ethnopharmacological and ethnomedicine properties of Vetiveria Zizanioides. Int J Allied Med Sci Clin Res. 2019;7:1.
   Google Scholar
• Balkrishna A, Pokhrel S, Singh H, et al. Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and Host ACE2 interactions to rescue spike protein induced pathologies in humanized zebrafish model. Drug Des Devel Ther. 2021;15:1111–1133. doi:10.2147/DDDT.S292805
   PubMed Web of Science ®Google Scholar
• Gupta GL, Rana AC. Withania somnifera (Ashwagandha): a review. Pharmacogn Rev. 2007;1(1):129–136.
   Google Scholar
• Davis L, Kuttan G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol. 2000;71(1–2):193–200. doi:10.1016/S0378-8741(99)00206-810904163
   PubMed Web of Science ®Google Scholar
• Guo H, Zheng J, Huang G, et al. Xuebijing injection in the treatment of COVID-19: a retrospective case-control study. Ann Palliat Care. 2020;9(5):5648.
   Google Scholar
• Yin Q, Li C. Treatment effects of Xuebijing injection in severe septic patients with disseminated intravascular coagulation. Evid Based Complement Altern Med. 2014;2014:1–6. doi:10.1155/2014/949254
   Web of Science ®Google Scholar
• Li S, Wang H, Sun Q, Liu B, Chang X. Therapeutic effect of Xuebijing, a traditional Chinese medicine injection, on rheumatoid arthritis. Evid Based Complement Altern Med. 2020;2020:1–9. doi:10.1155/2020/2710782
   Web of Science ®Google Scholar
• Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia. Crit Care Med. 2019;47(9):e735–e743. doi:10.1097/CCM.000000000000384231162191
   PubMed Web of Science ®Google Scholar
• Yu J-S, Ho C-H, Hsu Y-C, Wang -J-J, Hsieh C-L. Traditional Chinese medicine treatments for upper respiratory tract infections/common colds in Taiwan. Eur J Integr Med. 2014;6(5):538–544. doi:10.1016/j.eujim.2014.06.00332288884
   PubMed Web of Science ®Google Scholar
• Liew WK, Loh W, Chiang WC, Goh A, Chay OM, Iancovici Kidon M. Pilot study of the use of Yin Qiao San in children with conventional antipyretic hypersensitivity. Asia Pac Allergy. 2015;5(4):222. doi:10.5415/apallergy.2015.5.4.22226539405
   PubMedGoogle Scholar
• Duan X-H, Liu L-S, Lei NL, Lin Q, Wang W-L, Yan H-W. The effects and mechanism of Yinqiao powder on upper respiratory tract infection. Int J Biotechnol Wellness Ind. 2015;4(2):57–60. doi:10.6000/1927-3037.2015.04.02.2
   Google Scholar
• Yang Z-S, Yan J-Y, Han N-P, et al. Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β1 signaling suppression in rat model of COPD. Iran J Basic Med Sci. 2016;19(9):993–1002.27803787
   PubMed Web of Science ®Google Scholar
• He T, Qu R, Qin C, et al. Potential mechanisms of Chinese Herbal Medicine that implicated in the treatment of COVID-19 related renal injury. Saudi Pharm J. 2020;28(9):1138–1148. doi:10.1016/j.jsps.2020.08.00232837217
   PubMed Web of Science ®Google Scholar
• Du CYQ, Zheng KYZ, Bi CW, Dong TTX, Lin H, Tsim KWK. Yu Ping Feng San, an ancient Chinese Herbal Decoction, induces gene expression of anti-viral proteins and inhibits neuraminidase activity. Phyther Res. 2015;29(5):656–661. doi:10.1002/ptr.5290
   PubMed Web of Science ®Google Scholar
• Cyranoski D. Why Chinese medicine is heading for clinics around the world. Nature. 2018;561(7724):448–450. doi:10.1038/d41586-018-06782-730258149
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Banerjee M, Mandal V, Shukla AC, Mandal SC. Modernization of ayurveda: a brief overview of Indian initiatives. Nat Prod Commun. 2014;9(2):1934578X1400900. doi:10.1177/1934578X1400900239
   Web of Science ®Google Scholar
• Milden SP, Stokols D. Physicians’ attitudes and practices regarding complementary and alternative medicine. Behav Med. 2004;30(2):73–84. doi:10.3200/BMED.30.2.73-8415648127
   PubMed Web of Science ®Google Scholar
• Wahner-Roedler DL, Vincent A, Elkin PL, Loehrer LL, Cha SS, Bauer BA. Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: a survey at an academic medical center. Evid Based Complement Altern Med. 2006;3(4):495–501. doi:10.1093/ecam/nel036
   PubMed Web of Science ®Google Scholar
• Wahner-Roedler DL, Lee MC, Chon TY, Cha SS, Loehrer LL, Bauer BA. Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: 8-Year follow-up at an academic medical center. Complement Ther Clin Pract. 2014;20(1):54–60. doi:10.1016/j.ctcp.2013.09.00324439646
   PubMed Web of Science ®Google Scholar
• Tengku Mohamad TAS, Islahudin F, Jasamai M, Jamal JA. Preference, perception and predictors of herbal medicine use among Malay women in Malaysia. Patient Prefer Adherence. 2019;13:1829–1837. doi:10.2147/PPA.S22778031749609
   PubMed Web of Science ®Google Scholar
• Mothupi MC. Use of herbal medicine during pregnancy among women with access to public healthcare in Nairobi, Kenya: a cross-sectional survey. BMC Complement Altern Med. 2014;14(1):432. doi:10.1186/1472-6882-14-43225370478
   PubMed Web of Science ®Google Scholar
• Moreira D, Teixeira SS, Monteiro MHD, De-oliveira ACAX, Paumgartten FJR. Traditional use and safety of herbal medicines. Rev Bras Farmacogn. 2014;24(2):248–257. doi:10.1016/j.bjp.2014.03.006
   Google Scholar
• World Health Organization. Traditional medicine; 2013. https://apps.who.int/gb/ebwha/pdf_files/EB134/B134_24-en.pdf. Accessed 9 October, 2021.
   Google Scholar
• Tabish SA. Complementary and alternative healthcare: is it evidence-based? Int J Heal Sci. 2008;2(1):5–9.
   Google Scholar
• Du Toit A, van der Kooy F. Artemisia afra, a controversial herbal remedy or a treasure trove of new drugs? J Ethnopharmacol. 2019;244:112127. doi:10.1016/j.jep.2019.11212731376515
   PubMed Web of Science ®Google Scholar
• Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evid Based Complement Altern Med. 2007;4(s1):37–40. doi:10.1093/ecam/nem096
   PubMed Web of Science ®Google Scholar
• Saghir SA, AlGabri NA, Alagawany MM, et al. Chloroquine and hydroxychloroquine for the prevention and treatment of COVID-19: a fiction, hope or hype? An updated review. Ther Clin Risk Manag. 2021;17:371–387. doi:10.2147/TCRM.S30181733953559
   PubMed Web of Science ®Google Scholar
• Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N Engl J Med. 2020;383(21):2041–2052. doi:10.1056/NEJMoa201901432706953
   PubMed Web of Science ®Google Scholar
• Skipper CP, Pastick KA, Engen NW, et al. Hydroxychloroquine in nonhospitalized adults with early COVID-19. Ann Intern Med. 2020;173(8):623–631. doi:10.7326/M20-420732673060
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Mösbauer K, Hofmann-Winkler H, et al. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020;585(7826):588–590. doi:10.1038/s41586-020-2575-332698190
   PubMed Web of Science ®Google Scholar
• Sriwijitalai W, Wiwanitkit V. Exaggerated information and COVID‐19 outbreak. Eur J Clin Invest. 2020;50:5. doi:10.1111/eci.13226
   Web of Science ®Google Scholar
• Niburski K, Niburski O. Impact of Trump’s promotion of unproven COVID-19 treatments on social media and subsequent internet trends: observational study. J Med Internet Res. 2020;22(11):e20044. doi:10.2196/2004433151895
   PubMed Web of Science ®Google Scholar
• Tollefson J. How Trump damaged science — and why it could take decades to recover. Nature. 2020;586(7828):190–194. doi:10.1038/d41586-020-02800-933020603
   PubMed Web of Science ®Google Scholar
• McLaughlin DM, Mewhirter J, Sanders R. The belief that politics drive scientific research & its impact on COVID-19 risk assessment. PLoS One. 2021;16(4):e0249937. doi:10.1371/journal.pone.024993733882088
   PubMed Web of Science ®Google Scholar
• Agley J, Xiao Y. Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science. BMC Public Health. 2021;21(1):89. doi:10.1186/s12889-020-10103-x33413219
   PubMed Web of Science ®Google Scholar
• Caulfield T. Pseudoscience and COVID-19 — we’ve had enough already. Nature. 2020. doi:10.1038/d41586-020-01266-z
   Google Scholar
• The House of Representatives of the Republic of Indonesia. House Proactively Joins the Fight against COVID-19. 2020. Accessed September 20, 2021. https://www.dpr.go.id/en/berita/detail/id/28652/t/House+Proactively+Joins+the+Fight+against+COVID-19.
   Google Scholar
• Enders AM, Uscinski JE, Klofstad C, Stoler J. The different forms of COVID-19 misinformation and their consequences. Harvard Kennedy Sch Misinformation Rev. 2020. doi:10.37016/mr-2020-48
   Google Scholar
• Demaio A. Local wisdom and health promotion: barrier or catalyst? Asia Pacific J Public Heal. 2011;23(2):127–132. doi:10.1177/1010539509339607
   Web of Science ®Google Scholar
• Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4. doi:10.3389/fphar.2013.0017724478704
   PubMed Web of Science ®Google Scholar
• Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: a review of their mechanisms, pros and cons. Evid Based Complement Altern Med. 2020;2020:1–12. doi:10.1155/2020/2560645
   Web of Science ®Google Scholar
• Fan AY, Gu S, Alemi SF. Chinese herbal medicine for COVID-19: current evidence with systematic review and meta-analysis. J Integr Med. 2020;18(5):385–394. doi:10.1016/j.joim.2020.07.00832792254
   PubMed Web of Science ®Google Scholar
• Thakkar S, Anklam E, Xu A, et al. Regulatory landscape of dietary supplements and herbal medicines from a global perspective. Regul Toxicol Pharmacol. 2020;114:104647. doi:10.1016/j.yrtph.2020.10464732305367
   PubMed Web of Science ®Google Scholar
• Jones AW. Early drug discovery and the rise of pharmaceutical chemistry. Drug Test Anal. 2011;3(6):337–344. doi:10.1002/dta.30121698778
   PubMed Web of Science ®Google Scholar
• Fofana MO. Decolonising global health in the time of COVID-19. Glob Public Health. 2021;16(8–9):1155–1166. doi:10.1080/17441692.2020.186475433370211
   PubMed Web of Science ®Google Scholar
• Lau TF, Leung PC, Wong ELY, et al. Using herbal medicine as a means of prevention experience during the SARS crisis. Am J Chin Med. 2005;33(03):345–356. doi:10.1142/S0192415X0500296516047553
   PubMed Web of Science ®Google Scholar
• Panyod S, Ho C-T, Sheen L-Y. Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective. J Tradit Complement Med. 2020;10(4):420–427. doi:10.1016/j.jtcme.2020.05.00432691006
   PubMedGoogle Scholar
• Jonas WB. Building an evidence house: challenges and solutions to research in complementary and alternative medicine. Complement Med Res. 2005;12(3):159–167. doi:10.1159/000085412
   Web of Science ®Google Scholar